Progression of Advanced Chronic Hepatitis C (CHC): Further Follow-up Results From the Halt-C Trial

被引：0
|
作者：
Dienstag, Jules L.
Bonkovsky, Herbert L.
Kim, Hae-Young
Seeff, Leonard B.
Di Bisceglie, Adrian M.
Szabo, Gyongyi
Wright, Elizabeth C.
机构：
来源：
GASTROENTEROLOGY | 2010年 / 138卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
237
引用
收藏
页码：S780 / S781
页数：2
相关论文
共 50 条
  • [31] Statin Use Reduces Risk of Progression of Liver Fibrosis, Among Patients With Chronic Hepatitis C: Analysis of the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial
    Simon, Tracey G.
    King, Lindsay Y.
    Zheng, Hui
    Chung, Raymond T.
    GASTROENTEROLOGY, 2014, 146 (05) : S966 - S966
  • [32] Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: Results of the HALT-C cohort
    Lok, ASF
    Ghany, MG
    Goodman, ZD
    Wright, EC
    Everson, GT
    Sterling, RK
    Everhart, JE
    Lindsay, KL
    Bonkovsky, HL
    Di Bisceglie, AM
    Lee, WM
    Morgan, TR
    Dienstag, JL
    Morishima, C
    HEPATOLOGY, 2005, 42 (02) : 282 - 292
  • [33] IS THE PLATELET COUNT DETERMINED BY HEPATIC FUNCTION OR HYPERSPLENISM: RESULTS OF THE HALT-C TRIAL?
    Hoefs, John C.
    Everson, Gregory T.
    Shiffman, Mitchell L.
    Morgan, Timothy
    Chen, Wen-Pin
    Gillen, Daniel
    HEPATOLOGY, 2011, 54 : 582A - 583A
  • [34] Host immune responses do not correlate with histologic injury: Baseline analysis of the HALT-C trial in advanced hepatitis C disease.
    Rothman, AL
    Morishima, C
    Ray, R
    Chang, M
    Bonkovsky, HL
    Di Bisceglie, A
    Lee, WM
    Lindsay, KL
    Gretch, DR
    Sullivan, DG
    Polyak, SJ
    Wright, EC
    Koziel, MJ
    HEPATOLOGY, 2003, 38 (04) : 467A - 467A
  • [35] The Effects of Angiotensin Blocking Agents on the Progression of Liver Fibrosis in the HALT-C Trial Cohort
    Barham K. Abu Dayyeh
    May Yang
    Jules L. Dienstag
    Raymond T. Chung
    Digestive Diseases and Sciences, 2011, 56 : 564 - 568
  • [36] The Effects of Angiotensin Blocking Agents on the Progression of Liver Fibrosis in the HALT-C Trial Cohort
    Abu Dayyeh, Barham K.
    Yang, May
    Dienstag, Jules L.
    Chung, Raymond T.
    DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (02) : 564 - 568
  • [37] Prolonged antiviral therapy with peginterferon to prevent complications of advanced liver disease associated with hepatitis C: Results of the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial
    Di Bisceglie, Adrian M.
    Shiffman, Mitchell L.
    Everson, Gregory T.
    Lindsay, Karen L.
    Everhart, James E.
    Wright, Elizabeth C.
    Lee, William M.
    Lok, Anna S.
    Bonkovsky, Herbert
    Morgan, Timothy R.
    Dienstag, Jules L.
    Ghany, Marc
    Morishima, Chihiro
    Snow, Kristin K.
    HEPATOLOGY, 2007, 46 (04) : 290A - 290A
  • [38] Complication Rate of Percutaneous Liver Biopsies Among Persons With Advanced Chronic Liver Disease in the HALT-C Trial
    Seeff, Leonard B.
    Everson, Gregory T.
    Morgan, Timothy R.
    Curto, Teresa M.
    Lee, William M.
    Ghany, Marc G.
    Shiffman, Mitchell L.
    Fontana, Robert J.
    Di Bisceglie, Adrian M.
    Bonkovsky, Herbert L.
    Dienstag, Jules L.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2010, 8 (10) : 877 - 883
  • [39] Reversible Myopathy Induced By Long-Term Pegasys Mono Treatment for a Chronic Hepatitis C Patient under HALT-C Trial
    Cai, Chunyu
    Gioaccotto, Josh
    Felice, Kevin
    Grunnet, Margaret
    Whitaker, Charles
    Wu, Qian
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2009, 68 (05): : 580 - 580
  • [40] Serum alpha-fetoprotein (AFP) levels in patients with advanced hepatitis C-associated liver disease without hepatocellular carcinoma: Results from the HALT-C trial.
    Di Bisceglie, AM
    Dienstag, J
    Bonkovsky, H
    Sterling, R
    Chung, R
    Everhart, J
    Wright, E
    HEPATOLOGY, 2003, 38 (04) : 434A - 434A
12345